Loading stock data...
Heron Therapeutics, Inc. (HRTX) Stock Price, Chart & Analysis
Heron Therapeutics, Inc.HRTX
Market Closed$1.30
$-0.03-2.26%
HRTX Market Indicators
Very Bearish
Market Sentiment
Historical Price Chart
View the historical price chart for HRTX to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
Heron Therapeutics, Inc. (HRTX)
Loading chart data...
Is Heron Therapeutics, Inc. (HRTX) Stock a Buy in 2025?
YES
BUY
Score: 78/100
Yes, HRTX stock appears to be a good buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether HRTX stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
Growth Drivers
- Strong revenue growth of 13.6%
- Healthcare sector momentum
Valuation Considerations
- Analyst price targets suggest 265.4% upside potential
- Small-cap with higher growth potential and volatility
Risk Factors
- Low current ratio indicates potential liquidity concerns
- Healthcare sector cyclicality
- Small-cap liquidity and volatility risks
Analyst Consensus
Buy Ratings:8
Hold Ratings:1
Sell Ratings:1
Avg. Price Target:$4.75
Upside Potential:265.4%
Investment Summary
HRTX presents a mixed investment profile for 2025. The company shows strong growth drivers including strong revenue growth of 13.6%, though analyst price targets suggest 265.4% upside potential.
Analyst sentiment is generally positive with 8 buy ratings vs 1 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly low current ratio indicates potential liquidity concerns, and consider their own risk tolerance and investment timeline.
Final Recommendation
BUY
Recommendation Score
Overall Score:78/100
Strong Buy
2030 Price Prediction
Predicted Price:$1.46
Potential Return:+12.3%
Key Factors
- Strong revenue growth
- Very strong analyst buy consensus
- Very significant upside potential
- Wide analyst target range indicates uncertainty
- Small-cap risks
- Debt-to-Market-Cap Ratio: 88.7% (Extremely High)
Investment Decision
Based on our comprehensive analysis of HRTX's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a BUY. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
hrtx Stock Price Prediction 2030
Predicted 2030 Price
$1.46
+12.3%from current price
Based on revenue growth analysis and market trends, hrtx stock is projected to reach $1.46 by 2030, representing a 12.3% increase from the current price of $1.30.
Current Price
$1.30
Revenue Growth
3.3%
Analyst Target
$4.75
View Full Prediction Analysis
Get detailed analyst targets, key factors, and comprehensive forecast analysis
How to Invest in hrtx Stock?
1. Research Fundamentals
Analyze financial statements and market position
2. Technical Analysis
Review price charts and technical indicators
3. Risk Assessment
Evaluate market and company-specific risks
4. Investment Decision
Make buy/hold/sell decision with price targets
Company Profile
Heron Therapeutics, Inc.
Healthcare
Biotechnology
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its propr...
Employees
122
Market Cap
$199.28M